KEYMED BIO-B: VOLUNTARY ANNOUNCEMENTTHE LATEST RESULTS FROM A PHASE I CLINICAL STUDY OFCMG901 (AZD0901) AT THE ASCO ANNUAL MEETING 2024 BY WAY OFORAL PRESENTATION

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.